Meet MMS Holdings at Booth #22!

Set in scenic La Jolla, Outsourcing in Clinical Trials (OCT) Southern California 2023 is more than an event—it’s where bio-pharma evolution meets solution-driven discussions. This September, attendees will dive into enlightening dialogues, network with industry peers, and glimpse the future of clinical trials. Join us for a transformative journey through the clinical landscape.

MMS Holdings stands as a leading Contract Research Organization, defining global standards in drug development and regulatory submissions. Our data-focused approach uniquely positions us to serve the pharmaceutical and biotech industries, offering unparalleled support in areas of regulatory strategy and submissions, medical writing, data management, programming/statistics, data science (including dashboard visualization/analytics), pharmacovigilance, transparency, quality/auditing, and expert consulting services. We support pharmaceutical and biotech companies of all sizes, such as Pfizer and MAPS, who trust our expertise. Our commitment to quality is underscored by distinguished recognitions like the “Trial of the Year” and “Best CRO”, as well as significant milestones:

• 70+ successful Marketing Application Submissions over the last 5 years.
• 0 refusals to file in our entire history.
• Successful submissions across 14 countries and Health Authorities.

“From the outset, we were struck by MMS’s efficiency and intelligent choices, always pushing to meet our deadlines and successfully bring our drug to market.”

– Mid-sized pharmaceutical client